Edwards Lifesciences Corporation (EW) Tops Q2 EPS by 10c, Raises Outlook

Go back to Edwards Lifesciences Corporation (EW) Tops Q2 EPS by 10c, Raises Outlook

Edwards Lifesciences (EW) PT Raised to $150 at Morgan Stanley

July 27, 2018 7:44 AM EDT

Morgan Stanley raised its price target on Edwards Lifesciences (NYSE: EW) to $150.00 (from $138.00) while maintaining a Overweight rating.

... More